Madagascar

PSI Madagascar provides quality sexual and reproductive health services to reach Malagasy national objectives, as well as the international Family Planning 2020 goals, and to expand contraceptive method choice across the country. PSI Madagascar works with the Malagasy government to integrate innovative sexual and reproductive health programs into private networks and public facilities to reach rural and remote areas with mobile clinic services.

To reduce maternal mortality and morbidity, PSI Madagascar expands access to quality post-abortion care services and harm reduction counseling in 18 regions of the country. PSI Madagascar also works with the Malagasy government to integrate innovative maternal health programs into private networks and public facilities. As part of this work, PSI Madagascar successfully registered Ace Miso as the first misoprostol for gynecological indications and distributes it nationwide.

As a principal recipient of the Global Fund, PSI Madagascar focuses on prevention activities to reduce the number of new HIV infections among key populations and the general population by the end of 2020. PSI Madagascar’s work expands facility and community-based HIV prevention, testing, treatment and care services for key populations in 22 regions.

To reach the goal of targeted geographic and progressive malaria in Madagascar, PSI Madagascar works with the Malagasy Ministry of Health and the National Malaria Control Program to provide access to high quality rapid diagnostic tests and antimalarial drugs, as well as insecticide-treated nets. PSI Madagascar also supports microscopy diagnosis improvement and surveillance for the elimination of malaria in two districts.